EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interaction Between CYP1A2-Related Caffeine Metabolism and Vitamin B12/Folate Status in Patients with Metabolic Syndrome: A Novel Biomarker Axis

Laura Claudia Popa iD, Ahmed Abu-Awwad iD, Simona Sorina Farcas, Simona-Alina Abu-Awwad iD, Nicoleta Ioana Andreescu iD

Metabolites · 04.07.2025 · 15 (7) · 450

DOI: 10.3390/metabo15070450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 04.07.2025. Verfasst von Laura Claudia Popa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes, University of Medicine and Pharmacy, Timisoara, Victor Babes University of Medicine and Pharmacy, Timisoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The prevalence of metabolic syndrome (MetS) is steadily increasing worldwide, driven by complex genetic, nutritional, and environmental factors. Caffeine metabolism, primarily mediated by CYP1A2 (though other enzymes such as CYP1A1 may also be involved), and the status of micronutrients such as vitamin B12 and folate have each been linked to MetS components. This study investigates the interaction between CYP1A2 genetic variants and vitamin B12/folate levels in patients with MetS, aiming to identify a novel biomarker axis with potential implications for personalized interventions.

Methods

This cross-sectional observational study included 356 adults diagnosed with MetS, recruited from Western Romania. Genotyping for CYP1A2 rs762551 was performed using TaqMan PCR assays. Daily caffeine intake was assessed via validated dietary questionnaires. Serum levels of folate and vitamin B12 were measured using chemiluminescence immunoassays.

Results

AA genotype patients with a moderate coffee intake (1–2 cups/day) had significantly higher folate and B12 levels than AC or CC carriers. These nutritional advantages were associated with more favorable BMI and triglyceride profiles. The interaction between CYP1A2 genotype and coffee intake was significant for both micronutrient levels and metabolic parameters, particularly in the AA group. No significant associations were found in high-coffee-intake subgroups (≥3 cups/day).

Conclusions

The interplay between CYP1A2 polymorphisms and B-vitamin status may represent a clinically relevant biomarker axis in MetS. Moderate caffeine intake in slow metabolizers (AA genotype) may boost micronutrient status and metabolic health, supporting personalized nutrition.

Schlagwörter

Stichwörter der Autor:innen

caffeine metabolismcytochrome P-450 CYP1A2folic acidmetabolic syndromepersonalized medicinevitamin B12

Autor:innen und Institutionen

  • Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
  • Department of Microscopic Morphology, Discipline of Genetics, Genomic Medicine Centre "Victor Babes", University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • "Pius Brinzeu" Emergency Clinical County Hospital, Bld Liviu Rebreanu, No. 156, 300723 Timisoara, Romania.
  • Department XV-Discipline of Orthopedics-Traumatology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
  • Research Center University Professor Doctor Teodor Sora, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
  • Department XII, Discipline of Obstetrics and Gynecology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.

ORCID-Profile: Laura Claudia Popa, Ahmed Abu-Awwad, Simona-Alina Abu-Awwad, Nicoleta Ioana Andreescu

Förderung

  • Victor Babes, University of Medicine and Pharmacy, Timisoara
  • Victor Babes University of Medicine and Pharmacy, Timisoara

Zitieren

APA

Popa, L. C., Abu-Awwad, A., Farcas, S. S., Abu-Awwad, S. A., & Andreescu, N. I. (2025). Interaction Between CYP1A2-Related Caffeine Metabolism and Vitamin B12/Folate Status in Patients with Metabolic Syndrome: A Novel Biomarker Axis. Metabolites, 15(7), 450. https://doi.org/10.3390/metabo15070450

Vancouver

Popa LC, Abu-Awwad A, Farcas SS, Abu-Awwad SA, Andreescu NI. Interaction Between CYP1A2-Related Caffeine Metabolism and Vitamin B12/Folate Status in Patients with Metabolic Syndrome: A Novel Biomarker Axis. Metabolites. 2025;15(7):450. doi:10.3390/metabo15070450

BibTeX
@article{Popa2025,
  author = {Popa, Laura Claudia and Abu-Awwad, Ahmed and Farcas, Simona Sorina and Abu-Awwad, Simona-Alina and Andreescu, Nicoleta Ioana},
  title = {Interaction Between CYP1A2-Related Caffeine Metabolism and Vitamin B12/Folate Status in Patients with Metabolic Syndrome: A Novel Biomarker Axis},
  journal = {Metabolites},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {450},
  doi = {10.3390/metabo15070450}
}
Kostenlos starten →